Late‐Breaking Abstract Presentations Published: 2026 15:45 – 16:00 LB01 | Nationwide Population‐Based Study of Toxoplasmosis Screening, Prenatal Management and Transmission in France (TOXOPERINAT Study) Laurent Mandelbrot1; Johann Kuhn2; François Kieffer3; Isabelle Villena4; Martine Wallon5; Sarah Tubiana2 1Hôpital Louis‐Mourier, Assistance Publique–Hôpitaux de Paris (AP‐HP), Colombes, France; 2Assistance Publique–Hôpitaux de Paris (AP‐HP), Paris, France; 3Assistance Publique–Hôpitaux de Paris (AP‐HP), Paris, France; 4Laboratoire de Parasitologie‐Mycologie, Centre National de Référence de la Toxoplasmose, CHU de Reims, Reims, France; 5Hospices Civils de Lyon (CHU de Lyon), Lyon, France Objective: Because the French program to prevent congenital toxoplasmosis is challenged despite new guidelines in 2020, we aimed to describe toxoplasmosis screening and prenatal management (antiparasitic prophylaxis and prenatal diagnosis) and estimate the frequency of maternal and congenital toxoplasmosis. Study Design: A nationwide study included all live births recorded in the French National Health Data System from 2018 to 2023. Healthcare reimbursement data were used to identify toxoplasmosis screening, antiparasitic treatment, and prenatal diagnosis. Algorithms combining reimbursements and hospital discharge diagnoses were developed to identify maternal and congenital toxoplasmosis. Results: Among 3,828,621 singleton live births, maternal toxoplasmosis serology was performed in 97% of pregnancies, with a median of 6 tests [IQR 2;7]. Baseline seroprevalence was estimated at 27%, based on women who had ≤2 screening tests. Overall, maternal toxoplasmosis was identified in 8765 pregnancies (2.29 per 1000), with stable incidence over the study period. Antiparasitic prophylaxis was identified in 5275 pregnancies (1.38 per 1000). Among women treated during the 1st trimester, 99% received spiramycin. After 14 WG, prescriptions of pyrimethamine/sulfadiazine increased from 12.5% in 2018 to 44% in 2023, mostly in late pregnancy. Among treated women, prenatal diagnosis was performed in 2293 pregnancies (43.5%), with an increase over time. Among infants born to treated mothers, congenital toxoplasmosis estimates ranged from 154 to 836 cases (2.9%–15.8%) depending on the algorithm used, while 2581 (49%) lacked postnatal serological follow‐up. Conclusion: Antenatal screening coverage was high and prenatal management evolved following new guidelines. However, women with previous immunity were over‐tested, prophylaxis with pyrimethamine/sulfadiazine in the 2d–3d trimesters and prenatal diagnosis remained suboptimal, and postnatal follow‐up of exposed infants was insufficient, limiting reliable estimation of congenital toxoplasmosis; this highlights key areas for improving the French prevention program. Oral Concurrent 5 – Diabetes and Nutrition Friday, 9 October 2026 09:00 – 11:00 10:45 – 11:00 LB02 | Mistreatment During Childbirth in Nigeria: A Mixed‐Methods Study of Prevalence and Drivers Debra Eluobaju1; Friday Okonofua2; Marika Toscano3; Chiung Grace chen1; Gelila Goba4; Ahizechukwu C. Eke5 1The Johns Hopkins Hospital, Baltimore, MD; 2University of Benin Teaching Hospital, Department of Obstetrics and Gynaecology, Benin City, Nigeria; 3Johns Hopkins University, Baltimore, MD; 4University of Miami Health System, Department of Obstetrics and Gynecology, Miami, FL; 5Johns Hopkins University School of Medicine, Baltimore, MD Objective: To assess the prevalence, forms, and drivers of mistreatment during facility‐based childbirth in Benin City, Nigeria, integrating perspectives of postpartum women and skilled birth attendants (SBAs). Study Design: A convergent parallel mixed‐methods study was conducted July–August 2024 across three facilities (tertiary, secondary, private) in Benin City. Postpartum women (≤12 months since delivery) completed a 45‐item mistreatment survey (n = 656) assessing eight domains. Descriptive statistics and chi‐square analyses were performed. In‐depth interviews with postpartum women (n = 20) and four focus group discussions with SBAs (n = 26) were analyzed using constructivist grounded theory. Findings were integrated using a joint display matrix. Results: Overall, 89.5% of women reported at least one form of mistreatment, yet only 2.6% labeled their experience as such. The most prevalent domains were undignified care (70.0%) and loss of autonomy (48.2%), followed by physical abuse (37.5%) and abandonment (16.3%). Vaginal delivery (p = 0.030), higher education (p = 0.046), and antenatal care attendance (p = 0.020) were significantly associated with mistreatment. Qualitative analysis identified five themes: divergent expectations between women and SBAs; shared labeling of women as “uncooperative”; inconsistent definitions of mistreatment; provider burnout; and structural constraints including understaffing and financial barriers. Integration showed strong convergence between quantitative autonomy violations and qualitative accounts of restricted companionship and hierarchical communication. The gap between high prevalence and low self‐identification was explained by normalization of poor‐quality care. Conclusion: Mistreatment during childbirth in urban Nigeria is highly prevalent and structurally embedded. The discrepancy between reported experiences and self‐recognition reflects normalization sustained by workforce shortages and institutional norms. Improving outcomes requires integrated strategies addressing workforce capacity, accountability, and rights‐based education. Oral Concurrent 9 – Placental Disease and Associated Hypertension Friday, 9 October 2026 13:45 – 15:45 15:30 – 15:45 LB03 | Postpartum Blood Pressure Phenotypes One Year After Preeclampsia Sahil Sabnani1; Marte van der Bijl1; Jorie Versmissen1; Langeza Saleh2; Eric Boersma3; Johannes J. J. Duvekot4; A.H. Jan Danser1; Jeanine Roeters van Lennep1; Koen Verdonk4 On behalf of Erasmus Medical Center 1Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands; 2Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, Netherlands; 3Department of Cardiology, Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands; 4Erasmus University Medical Center, Rotterdam, Netherlands Objective: Despite the increased cardiovascular risk after preeclampsia, postpartum blood pressure phenotypes remain poorly defined. We aimed to characterize ambulatory blood pressure (BP) phenotypes and nocturnal dipping patterns one year postpartum. Study Design: In this prospective cohort study, women with severe preeclampsia (defined as early‐onset preeclampsia or preeclampsia with severe features) underwent standardized office blood pressure measurement and 24‐hour ambulatory blood pressure monitoring (ABPM) 9–18 months postpartum (one ABPM per participant). Nocturnal dipping patterns and ambulatory blood pressure phenotypes were classified according to European Society of Hypertension definitions. Additionally, a prevention‐oriented high‐normal ABPM category was defined to identify subthreshold ambulatory blood pressure elevations. Multivariable logistic regression identified determinants of abnormal blood pressure. Results: Among 432 women assessed at a median follow‐up of 13 months, 290 (67%) exhibited an abnormal ambulatory blood pressure phenotype. High‐normal ABPM was the most common abnormal phenotype (28%), followed by white‐coat hypertension (15%), sustained hypertension (15%), and masked hypertension (9%). High‐normal ABPM shared several cardiovascular risk characteristics with hypertensive phenotypes. Non‐ or reverse‐dipping patterns occurred in 39% of participants. Higher BMI, glycated hemoglobin, urine protein‐to‐creatinine ratio, and pre‐existing hypertension were independently associated with abnormal blood pressure, with pre‐existing hypertension showing the strongest association (aOR 8.45, 95% CI, 1.94–37). Conclusion: Nearly two‐thirds of women exhibited abnormal ambulatory blood pressure one year after severe preeclampsia, of whom 168 (39%) would have remained undetected by office measurements alone. High‐normal ABPM was the most prevalent abnormal phenotype. These findings support the added value of ABPM and suggest that women with high‐normal ABPM represent a clinically relevant subgroup warranting closer postpartum follow‐up. Poster Session 1 Thursday, 8 October 2026 11:15 – 12:30 11:15 – 12:30 LB04 | Phenotyping Late‐Onset Fetal Growth Restriction: Associations With Neonatal Outcomes Esraa Alsafri McMaster University Hospital, Hamilton, Canada Objective: To phenotype late‐onset pregnancies using birthweight severity and Delphi consensus‐aligned Doppler criteria, distinguishing SGA from FGR and stratifying FGR severity, and to determine associations between phenotypes and neonatal outcomes. Study Design: This retrospective cohort study examined singleton pregnancies with suspected FGR undergoing Doppler surveillance and delivered at ≥32 weeks between January 2016 and December 2024 at a tertiary fetal medicine center. Four phenotype groups were defined using birthweight (Hadlock percentiles as proxy for estimated fetal weight, given ultrasound within 14 days of delivery) and last Doppler assessment: Group 0 (birthweight 3rd‐10th centile, normal Doppler) representing SGA; Group 1 (birthweight 3rd‐10th centile, abnormal Doppler); Group 2 (birthweight <3rd centile, normal Doppler); and Group 3 (birthweight <3rd centile, abnormal Doppler), with Groups 1–3 representing FGR per Delphi criteria. Abnormal Doppler was defined as umbilical artery pulsatility index >95th centile or cerebroplacental ratio <5th centile. The primary outcome was a composite of adverse neonatal outcomes. Results: Among 1771 pregnancies, 765 (43.2%) were classified as SGA and 1006 (56.8%) met FGR criteria. Composite adverse outcome rates increased across phenotypes from 29.2% in SGA to 38.3%, 42.9%, and 66.1% in Groups 1–3, respectively (p < 0.001). Compared with SGA, adjusted risk was higher in Group 1 (aRR 1.26, 95% CI, 1.05–1.52), Group 2 (aRR 1.47, 95% CI, 1.25–1.72), and Group 3 (aRR 2.02, 95% CI, 1.77–2.31). Cesarean delivery for non‐reassuring fetal heart rate increased from 0.7% in SGA to 14.2% in Group 3 (p < 0.001). Conclusion: Combining birthweight severity with Delphi‐aligned Doppler criteria distinguishes SGA from FGR and identifies FGR phenotypes with substantially different neonatal risks. This classification provides clinically meaningful risk stratification that may improve counseling and management. 11:15 – 12:30 LB05 | Placental NRF2/Mitochondrial N‐Formyl Peptide/FPR1 Axis Triggers Preterm Birth via Inflammation‐Contraction Way Chaolu Chen; Tiantian Fu; Danqing Chen Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China (People's Republic) Objective: Preterm birth, recognized as delivery before 37 weeks of gestation, is a multifactorial syndrome characterizing as the main cause of neonatal mortality. This study aims to elucidate the upstream molecular mechanism governing the transition of the uterus from a quiescent gestational state to an active labor state, focusing on the placental NRF2–mitochondrial function–mitochondrial N‐formyl peptides (mtFPs)–FPR1 axis, to provide a scientific basis for the etiological understanding and precise management of preterm birth. Study Design: Human placenta samples and clinical data of participants were collected to ascertain whether placental NRF2 expression, mitochondrial dysfunction, mtFPs levels were associated with preterm birth. Lipopolysaccharide (LPS)‐induced preterm birth mouse model was used to examine the protective effects of mtFPs on preterm birth. Results: Here, we found that preterm placentas had abnormal mitochondrial function, impaired metabolic function and elevated mtFPs levels. mtFPs activated neutrophils to trigger sterile placental inflammation, and their receptor FPR1 directly promoted myometrial contraction. Downregulation of NRF2 in trophoblasts induced mitochondrial dysfunction and mtFPs release, which further drove inflammatory responses and uterine contractility via FPR1 signaling. Conclusion: Placental NRF2 deficiency triggers mitochondrial dysfunction and mtFPs release, which activate FPR1 to promote placental inflammation and uterine contraction, ultimately leading to premature labor onset. These findings enrich the etiological theory of preterm birth and identify potential targets for the prediction and treatment of preterm birth. 11:15 – 12:30 LB06 | PDK1 Enhances Lactate Accumulation Driving Placental Inflammation and Preterm Labor Tiantian Fu; Chaolu Chen; Danqing Chen Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China (People's Republic) Objective: Preterm labor (PTL) is strongly associated with intrauterine inflammation, yet the upstream metabolic drivers of this cascade remain incompletely understood. The objective of this study was to investigate the role of pyruvate dehydrogenase kinase 1 (PDK1)‐mediated metabolic reprogramming, specifically enhanced glycolysis and lactate accumulation in trophoblasts, in driving placental inflammation and PTL. Study Design: We examined placental tissues collected from patients with PTL and normal term labor (TL) to evaluate PDK1 expression, glycolytic activity, and lactate levels. To determine causality, a lipopolysaccharide (LPS)‐induced PTL mouse model was utilized. Mice were treated with dichloroacetate (DCA), a pharmacological inhibitor of PDK1, to assess its effects on placental PDK1 expression, phosphorylated pyruvate dehydrogenase E1 alpha 1 (p‐PDHA1), lactate accumulation, and intrauterine inflammation. Furthermore, RNA sequencing and molecular analyses were conducted in trophoblasts to elucidate the mechanistic link between lactate and pro‐inflammatory cytokine production. Results: Compared to TL controls, PTL placentas exhibited significantly upregulated PDK1, corresponding with increased glycolytic activity and profound lactate accumulation. In the LPS‐induced PTL mouse model, PDK1 inhibition with DCA suppressed placental PDK1 expression and p‐PDHA1 levels. Consequently, DCA significantly reduced lactate in placenta and amniotic fluid, attenuating intrauterine inflammation and preventing PTL. Mechanistically, RNA sequencing and molecular validation confirmed lactate directly stimulates pro‐inflammatory cytokine production in trophoblasts, an effect abrogated by DCA. Conclusion: PDK1 acts as a critical upstream metabolic regulator in trophoblasts, driving lactate accumulation that promotes placental inflammation and subsequent preterm birth. Targeting the PDK1‐lactate metabolic axis with inhibitors like DCA represents a promising therapeutic strategy for the prevention and clinical management of PTL. 11:15 – 12:30 LB07 | Acceptability and Feasibility of a Smartphone App System for Home Blood Pressure Monitoring in Ghana Emma Lawrence1; Perez Sepenu2; Betty Nartey2; Clara Buxton2; Gloria Codjoe2; Gloria OSEI OWUSU2; Roxanne Harfmann1; Cheryl Moyer1; Jody Lori1; Samuel Oppong3 1University of Michigan, Ann Arbor, MI; 2Korle Bu Teaching Hospital, Accra, Ghana; 3University of Ghana, Accra, Ghana Objective: Home blood pressure (BP) monitoring is a promising strategy to detect preeclampsia earlier. However, significant health literacy, numeracy, and language barriers exist in low‐resource settings. The objective of this study was to evaluate the feasibility and acceptability of home BP monitoring in Ghana, augmented with a smartphone app system adapted to the Ghanaian context. Study Design: Participants were adult pregnant patients engaged in antenatal care at a tertiary hospital in Ghana. Participants were enrolled (Visit 1), trained on the use of the smartphone app and home BP monitor (Visit 2), engaged in daily home BP monitoring for four weeks, then and completed post‐monitoring surveys on acceptability, appropriateness, feasibility, barriers and motivators, and user experiences (Visit 3). Results: Among 67 participants, mean acceptability (Acceptability of Intervention Measure) was 4.4 out of 5 and mean feasibility (Feasibility of Intervention Measure) was 4.5 out of 5. Participants’ greatest challenge was remembering to check their BP at home (21, 31.8%), while their greatest motivator was believing that blood pressure in pregnancy is important (45, 67.2%). On a 10 point score ranging from 1 (very small agreement) to 10 (very big agreement), participants reported the app system was easy to understand (mean 9.3), felt comfortable using it (mean 9.2), felt it was clear when their BP values were abnormal (mean 9.4)), and would recommend the system (mean 9.7). Conclusion: Smartphone‐app based home BP monitoring, adapted to a low‐resource setting, demonstrated high acceptability and feasibility. Key barriers, including forgetting to monitor, need to be addressed. 11:15 – 12:30 LB08 | Maternal Gut‐Liver Axis Dysregulation in Gestational Diabetes Mediates Fetal Metabolic Programming Sanzhar Nurgaliuly Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan Objective: Gestational diabetes mellitus (GDM) is a common pregnancy complication with adverse outcomes for mother and offspring. The gut‐liver axis plays a crucial role in metabolic health, yet its contribution to GDM‐related fetal programming remains unexplored. This study investigated whether GDM‐induced gut dysbiosis and altered bile acid metabolism mediate fetal metabolic programming. Study Design: This prospective observational cohort study enrolled 150 women with GDM and 150 normoglycemic controls at delivery. Maternal stool, blood, and cord blood were collected. Gut microbiome was analyzed by 16S rRNA sequencing. Serum and cord blood metabolomics profiled bile acids and short‐chain fatty acids (SCFAs). Maternal liver enzymes and total bile acids (TBA) were measured. Fetal outcomes included birth weight and congenital anomalies. Findings were validated in a GDM mouse model. Results: GDM patients exhibited reduced gut microbial diversity with decreased SCFA‐producing genera (Bifidobacterium, Lactobacillus) and increased Enterococcus (p < 0.01). Serum SCFAs (acetate, propionate, butyrate) were significantly reduced, while TBA levels were elevated in GDM versus controls (p < 0.001). Maternal liver enzymes (ALT, AST) correlated positively with TBA levels (r = 0.62, p < 0.01). GDM women had higher rates of fetal macrosomia (25% vs 8%, p < 0.01) and increased risk of congenital anomalies of the kidney and urinary tract (CAKUT) (12% vs 4%, p = 0.02). In the GDM mouse model, maternal SCFA deficiency impaired fetal renal cell proliferation via diminished GPR43 signaling. SCFA restoration in maternal diet rescued these defects. Conclusion: GDM‐associated gut dysbiosis alters SCFA and bile acid metabolism, disrupting the maternal gut‐liver axis and contributing to fetal metabolic programming, including macrosomia and renal anomalies. These findings identify the gut‐liver axis as a potential therapeutic target to improve fetal outcomes in GDM pregnancies. 11:15 – 12:30 LB09 | Predictors of Intact Survival of Both Twins in Early‐Onset sFGR in MCDA Twin Pregnancies Asma Khalil1; Odai Yaghi2; Smriti Prasad3; Kelsey Lennox4; Richard Jackson5; Andrew Sharp6 On behalf of the FERN study group 1City St George's, University of London, London, United Kingdom; 2City, St George's University of London, London, United Kingdom; 3St George's University Hospitals NHS Foundation Trust, London, United Kingdom; 4Liverpool Women's Hospital, Liverpool, United Kingdom; 5Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; 6Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom Objective: To determine the rate of intact survival of both twins and identify antenatal predictors of intact dual survival in MCDA pregnancies complicated by early‐onset sFGR. Study Design: This secondary analysis included prospectively collected data from the FERN cohort of MCDA twins diagnosed with sFGR between 16 + 0 and 23 + 6 weeks’ gestation. sFGR was defined as EFW <10th centile in one twin with >25% intertwin discordance. The primary outcome was intact survival of both twins, defined as survival to discharge without major neonatal morbidity. Univariable and multivariable logistic regression analyses were performed. Two prespecified multivariable models were constructed: Model 1 included GA at diagnosis, EFW discordance, and Gratacós classification at diagnosis. Model 2 replaced classification at diagnosis with classification at the end of pregnancy. Model discrimination was assessed using the AUC, and models were compared using the DeLong test. Results: Ninety‐one pregnancies were included. Intact survival of both twins was achieved in 62.6% (57/91). When stratified by Gratacós Type at diagnosis, intact survival occurred in 70% of Type I, 53.8% of Type II, and 53.3% of Type III pregnancies (p = 0.279). In contrast, intact survival differed significantly according to Type at the end of pregnancy, occurring in 74.5% of Type I, 34.8% of Type II, and 64.7% of Type III pregnancies (p = 0.005). Later GA at diagnosis independently increased the odds of intact survival (adjusted OR 1.37 per week, 95% CI, 1.11–1.74; p = 0.005), while increasing EFW discordance reduced it (adjusted OR 0.91 per 1% increase, 95% CI, 0.83–0.98; p = 0.017). Model 2 demonstrated higher discrimination than Model 1 (AUC 0.815 vs 0.762), although the difference between the two models did not reach statistical significance (p = 0.112). Conclusion: In MCDA twin pregnancies complicated by early‐onset sFGR, intact survival of both twins was achieved in 62.6% of pregnancies. Baseline Gratacós classification did not independently predict outcome, whereas Gratacós classification at the end of pregnancy improved prognostic discrimination for intact survival. Poster Session 2 Thursday, 8 October 2026 16:00 – 17:15 16:00 – 17:15 LB10 | HELLP Syndrome or Dengue? Navigating Overlapping Diagnoses in a Critically Ill Pregnant Patient Michelle O. Hubilla‐Naguiat On behalf of Makati Medical Center Makati Medical Center, Makati City, Philippines Objective: To describe the diagnostic dilemma, clinical decision‐making, and outcomes when DSS and HELLP syndrome present concurrently in a preterm pregnancy. Study Design: Single‐institution case report with clinical, laboratory, and imaging data reviewed from admission through discharge. Results: A 31‐year‐old G3P2 at 33 weeks presented with fever and hypotension (BP 70–100/33–80 mmHg). Dengue NS1 antigen was positive. Resuscitation was initiated; refractory hypotension required norepinephrine and central venous access. Concurrent severe hypokalemia (K 2.0 mEq/L) with renal potassium wasting raised suspicion for Bartter vs. Gitelman syndrome; viral thyroiditis confirmed by suppressed TSH, normal FT4, and negative TRAB. Antenatal corticosteroids were completed; fetal surveillance remained reassuring. Day two chest X‐ray confirmed pneumonia. By day three, platelet nadir 62, AST 149 U/L, LDH 793 U/L, and UPCR 1.47 emerged — attributable to either dengue thrombocytopenia or HELLP, precluding definitive diagnosis. Peripheral smear showed no schistocytes, deepening the ambiguity. Epigastric pain on day four amid unresolvable diagnostic overlap prompted multidisciplinary junta and decision to deliver. Cesarean section was performed with transfusion of 2 units platelets and 1 unit packed RBC. A live preterm male was born, 1,950 g, APGAR 9,9, 34‐week maturity; discharged day seven. Mother was discharged day nine with platelets 170 and resolving pneumonia. Conclusion: When DSS and HELLP co‐occur, overlapping hematologic and hepatic profiles can render definitive diagnosis impossible in real time. Management must be driven by clinical trajectory rather than diagnostic certainty, with a low threshold for delivery when maternal and fetal conditions converge — even without a singular confirmed etiology. 16:00 – 17:15 LB11 | Taking it to Heart: A Survey of Self‐Assessed Cardiovascular Risk in Pregnant People With Hypertension Sarah M. Dwyer; Levi J. Anderson; Laine Boitos; Hadley Katzman; Julia Erickson; Munira Mohamed; Hero Eisley; Cindy Kraly; Ashley M. Hesson University of Michigan, Ann Arbor, MI Objective: Despite a clear relationship between lifetime cardiac event rate and hypertension in pregnancy, counseling is infrequent and unsubstantial in prenatal care. This study assesses patient perspectives on their cardiovascular (CV) risk relative to recollections of provider counseling to identify opportunities for enhanced awareness and engagement in prevention. Study Design: Those with hypertensive disorders of pregnancy (HDPs) and chronic hypertension (HTN) were prospectively surveyed on income/ education level and perspectives regarding their CV risk using a written survey given either prenatally or during delivery admission; diagnosis and additional demography were chart abstracted. Self‐assessed CV risk was compared across those who did and did not recall: 1) being counseled on risk, 2) receiving recommendations to reduce risk. Student T, Fisher exact tests were used for analysis; multivariate models were constructed for self‐assessed quantitative 10‐year CV risk. Results: 56 surveys were collected: 48.2% (N = 27) with HTN and 51.8% (N = 29) with HDP; demographics are given in Table 1. Risk assessment did not vary by diagnosis (HDP vs HTN, p = 0.17). Participants’ self‐assessed 10‐year cardiac event rate was not affected by recollection of risk counseling (p = 0.70) but was reduced by having higher educational attainment (p = 0.05) and recalling reception of risk reduction strategies from providers (p < 0.01). Perceived event likelihood was not affected by participant's reported belief that they have a ‘heart problem’ (p = 0.65). In a multivariate model of self‐assessed 10‐year cardiac event risk (Table 2), provider counseling recollection was the only significant predictor of reduced risk. Conclusion: Those with hypertension in pregnancy who recalled CV risk reduction counseling had lower self‐assessed 10‐year event rate than those who did not recall receiving this counseling, irrespective of their demographics or views on severity of disease. Counseling with clear, memorable action for CV risk reduction in pregnancy may instill self‐efficacy beliefs in this at‐risk population. 16:00 – 17:15 LB12 | Heavy Metal Exposure is Associated With Dysregulation of VGLL3— An Immunologic Etiology of Preeclampsia Bambarendage Perera1; Olesya Plazyo2; Sean Harris2; Bethany Pace2; Sarah M. Dwyer2; Levi J. Anderson2; Johann Gudjonsson2; Ashley M. Hesson2 1University of California, Berkeley, Berkely, CA; 2University of Michigan, Ann Arbor, MI Objective: Heavy metals have been implicated in hypertensive disorders of pregnancy (HDP), but their role in pathogenesis has yet to be established. Heavy metal exposure is a testable, potentially modifiable HDP risk factor. Understanding their potentiation of HDPs relative to known mechanisms may identify target populations for whom heavy metal remediation may be an important risk reduction strategy. Study Design: C57BL/6J mouse placentas (N = 17)‐ balanced by fetal sex per litter‐ were compared between lead (Pb) exposed and control specimens. Pb exposure was initiated (32 ppm) via drinking water two weeks prior to mating and continued up to euthanasia at E13‐15; placentas were collected and bulk RNA sequenced. Human placentas were obtained (N = 8 HDP, N = 3 control; Table 1), processed, and single‐cell RNA sequenced. Analyses were performed in edgeR/ Seurat. Results: Pb‐exposed mouse placentas had a relative upregulation of Vgll3‐ a transcription co‐regulator in the Hippo pathway modulated by X‐chromosome‐encoded histone demethylases‐ in models including both fetal sexes and female‐only fetuses (p < 0.05, Table 2) when compared to controls. In human placentas, metallothionein 1a (MT1A, a heavy metal detoxicant) was upregulated in vascular smooth muscle (p = 0.02) and immunomodulatory endothelial cells (p = 0.03, Table 1) from HDP‐affected placentas vs controls. VGLL3 is disproportionately expressed in extravillous trophoblasts with the highest cell‐cell interactions between the MT1A‐upregulated vascular cell types. Conclusion: VGLL3 has been identified as a critical mediator in the immunologic mechanisms underlying HDPs and their overlap with autoimmunity. Its upregulation in Pb‐exposed mice points to immune dysregulation as a possible intermediary of the relationship between heavy metal levels and HDPs. Upregulation of a heavy metal detoxicant in HDP‐affected human placental vascular cell types with concomitantly increased VGLL3 expression further underlines the plausibility of this mechanism and its sex‐specific effects. Further study may inform preconception heavy metal screening for those with autoimmune phenotypes. 16:00 – 17:15 LB13 | Point‐of‐Care Ultrasound in the Assessment of the Small for Gestational Age Fetus Kelsey Lennox1; Richard Jackson2; Steven Lane2; Andrew Sharp3; Abi Merriel4; Asma Khalil5 1Liverpool Women's Hospital, Liverpool, United Kingdom; 2Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; 3Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; 4University of Liverpool, Liverpool, United Kingdom; 5City St George's, University of London, London, United Kingdom Objective: To determine the feasibility and acceptability of hand‐held point‐of‐care ultrasound (POCUS) assessment in patients undergoing ultrasound assessment of fetal growth and evaluate the validity of measurements compared with standard ultrasound for second and third trimester biometry. Study Design: Single‐site feasibility study with prospective data collection from patients attending routine assessment of suspected SGA fetus. We report agreement data from the fully recruited SGA cohort. Participants underwent hand‐held POCUS using a 3–5 MHz Vscan Air CL device and standard ultrasound. Fetal head circumference, abdominal circumference and femur length were measured with both and incorporated into Hadlock estimated fetal weight. Standard ultrasound measurements were blinded from the operator using an opaque card. The same sonographer performed both scans. Agreement was assessed using intraclass correlation coefficients (ICC) and Bland‐Altman limits of agreement; categorical outcomes used Kappa coefficients. Results: Between October 2025 and June 2026, 61 patients were scanned at median gestation 32 + 5 (range 21 + 0–40 + 3). Repeat inclusion was permitted; one patient was scanned twice. Paired scan assessments analysed n = 62. High agreement was observed for fetal presentation (κ 0.98, 95% CI, 0.88–1.00), placental location (κ 0.72, 95% CI, 0.67–0.92), and fetal viability (100%). Moderate agreement was observed for liquor volume (κ 0.49, 95% CI, −0.14–0.26). Biometric measurements showed high Bland‐Altman and ICC agreement: head circumference (5.78 mm, 95% CI, −9.26 mm–13.39 mm, ICC 1.00), abdominal circumference (12.64 mm, 95% CI, −23.10 mm–26.45 mm, ICC 0.98), and femur length (2.94 mm, 95% CI, −5.75 mm −5.78 mm, ICC 0.98). For fetal weight, Bland‐Altman standardised mean difference was 168.3 g (−286.0 g – 373.7 g), and ICC showed high agreement (0.99). Conclusion: Hand‐held POCUS demonstrated high agreement with standard ultrasound for fetal biometry in SGA fetuses. 16:00 – 17:15 LB14 | Diagnostic Performance of sFlt‐1/PlGF Biomarker Following Implementation at the University of Nebraska Medical Center Santiago Ortiz Barragan1; Mridula Ghotane1; Michelle Pieters1; Holly Robinson1; Abby Stevens1; Rebecca Rimsza1; Sarosh Rana2 1University of Nebraska Medical Center, Omaha, NE; 2University of Nebraska Medical Center; Nebraska Medicine, Omaha, NE Objective: Preeclampsia affects 2–8% of pregnancies and remains a leading cause of maternal and fetal morbidity and mortality worldwide.1 Angiogenic biomarkers (sFlt‐1 and PlGF) have emerged as validated tools for risk stratification in pregnant patients presenting with hypertensive disorders. The sFlt‐1/PlGF ratio was implemented clinically at UNMC in October 2025, but its real‐world diagnostic performance in this population has yet to be characterized. Study Design: We performed a retrospective chart review of pregnant patients who underwent sFlt‐1/PlGF testing at UNMC between October 2025 and May 2026. The primary outcome was development of preeclampsia with severe features within two weeks of testing. Sensitivity, specificity, NPV, and PPV were calculated. Maternal adverse outcomes included transaminitis, creatinine elevation, pulmonary edema, placental abruption, and disseminated intravascular coagulation (DIC). Neonatal adverse outcomes included fetal death and small for gestational age (SGA). Results: Among 139 patients, a positive sFlt‐1/PlGF ratio was found in 22 patients (15.8%). For preeclampsia with severe features within 2 weeks, the biomarker showed a sensitivity of 72.0%, specificity of 96.5%, PPV 81.8%, and NPV 94.0%. A positive test was associated with significantly increased risk of any adverse maternal or neonatal outcome (RR 3.99, 95% CI, 1.53–10.37; OR 5.11, 95% CI, 1.57–16.65). Conclusion: This single‐center retrospective study provides preliminary real‐world performance data on the sFlt‐1/PlGF ratio at UNMC following clinical implementation, contributing institutional‐level evidence to support its use as a risk stratification tool in hypertensive pregnant patients. Poster Session 3 Friday, 9 October 2026 11:00 – 12:15 11:00 – 12:15 LB15 | Classification of Brain Variants on Fetal Ultrasound: International Delphi Consensus Emmanuelle Lesieur1; Jameela Sheikh2; Beatrice Desnous3; Sanne J. Gordijn4; Wessel Ganzevoort5; Mona Massoud6; Nicolas Sananes7; Marc Althuser8; Marie Brasseur‐Daudruy9; Tullio Ghi10; Rabih Chaoui11; Gustavo Malinger12; Asma Khalil13; Edwin Quarello1 1Hôpital Saint‐Joseph, Marseille, France; 2National Health Service (NHS), United Kingdom; 3Assistance Publique–Hôpitaux de Marseille (AP‐HM), APHM, France; 4University Medical Center Groningen (UMCG), Groningen, Netherlands; 5Amsterdam UMC, Amsterdam; 6Department of Obstetrics and Gynecology, Hôpital Femme‐Mère‐Enfant, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Bron, France; 7American Hospital of Paris, Neuilly‐sur‐Seine, France; 8CHU Grenoble Alpes, Grenoble, France; 9CHU de Rouen Normandie, Rouen, France; 10Department of Woman and Child Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; 11Center for Prenatal Diagnosis and Human Genetics, Berlin, Germany; 12Gynecology and Obstetrics Sonography Unit, Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, Israel; 13City St George's, University of London, London, United Kingdom Objective: To develop an expert consensus classification and management framework for fetal brain findings identified on prenatal ultrasound that cannot be confidently categorised as either normal or pathological. Study Design: A two‐round international Delphi survey was conducted among experts in fetal neurosonography. Forty‐eight fetal brain findings illustrated with representative ultrasound images, were evaluated. Brain findings were classified into three categories: Green (no additional investigation or follow‐up), Orange (neurosonographic follow‐up), and Red (dedicated neurosonography, fetal brain magnetic resonance imaging (MRI), and/or genetic investigations). Results: Forty‐eight experts from 14 countries participated. Of the 48 evaluated variants, 12 were classified as Green, 7 as Orange, and 16 as Red. Green‐zone findings included isolated choroid plexus cysts across all trimesters, regular asymmetry of the choroid plexuses, isolated cavum septations, cavum vergae and velum interpositum, isolated small cavum septum pellucidum with intact corpus callosum, and dolichocephaly with normal head and brain morphology. Orange‐zone findings included, among other things, isolated enlargement of intracranial translucency with preserved anatomy, atypical choroid plexus cyst characteristics, mild enlargement of the cisterna magna, isolated enlargement of subarachnoid spaces without compression, and selected isolated cavum abnormalities. Red‐zone findings included, among other things, abnormal posterior fossa findings, dysmorphic asymmetric frontal horns, periventricular cysts associated with adjacent white matter abnormalities, thickened corpus callosum, distortion of the interhemispheric fissure, abnormal subarachnoid spaces with septations or echogenic irregularities, and pathological cranial shape abnormalities. Thirteen findings (27%) failed to reach consensus. Conclusion: This international Delphi consensus proposes an initial expert‐derived classification of commonly encountered fetal brain findings on ultrasound. Poster Session 4 Friday, 9 October 2026 15:45 – 17:00 LB16 | Diastolic Function in Preeclampsia Complicated by Pulmonary Edema Karl Bergman1; Catherine Anne Cluver2; Lina Bergman3; Siyo Sibeko4; Eduard Langenegger5; Henrik Imberg6; Erik Thunström1; Jacqui Thake2 1Department of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2Stellenbosch University, Stellenbosch, South Africa; 3Stellenbosch University, Stellenbosch, Sweden; 4Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa; 5Department of Obstetrics and Gynecology, Stellenbosch University, Stellenbosch, South Africa; 6Statistiska Konsultgruppen; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden Objective: Pulmonary edema is a severe complication of preeclampsia and accounts for up to 50% of preeclampsia related deaths. The underlying cause remains unclear. Diastolic dysfunction and increased afterload are proposed contributors. Therefore, the aim was to investigate the role of diastolic dysfunction in pulmonary edema among women with preeclampsia. Study Design: This was a prospective cohort study within the PROVE Biobank and Database at Tygerberg Hospital, Cape Town, South Africa. Preeclampsia and associated organ complications were diagnosed according to the definition by the International Society for the Study of Hypertension in Pregnancy. Significant proteinuria was required. Exposure was pulmonary edema and reference groups were preeclampsia with and without organ complications. Outcome was diastolic function assessed by echocardiography and classified into three categories: normal diastolic function, grade 1 diastolic dysfunction (normal filling pressures), and grade 2 diastolic dysfunction (elevated filling pressures). Results are presented as cumulative odds ratios (ORs) with 95% confidence intervals (CIs) using ordinal logistic regression. Results: Between 2018 and 2025, we included a 77 women with preeclampsia divided in groups pulmonary edema (n = 38), preeclampsia with organ complications (n = 13) and preeclampsia without organ complications (n = 26). A population‐based control group of normotensive women was also included (n = 30). Women with preeclampsia and pulmonary edema did not have diastolic dysfunction more often than women with other organ complications (16/38; 42% vs 2/12; 15%, OR 3.85 (95% CI, 0.77–19.43)) or women without organ complications (16/38; 42% vs 8/26; 31%, OR 1.45 (95% CI, 0.52–4.03)). Women with preeclampsia demonstrated diastolic dysfunction more often than the normotensive group (26/77; 33.8% vs 1/30; 3.7%, OR 14.8 (95% CI, 1.91–114.69)) Conclusion: Diastolic dysfunction does not seem to be the underlying cause to the development of pulmonary edema in preeclampsia. Blood pressure levels, inflammation and endothelial dysfunction in pulmonary edema need to be further explored. 15:45 – 17:00 LB17 | Community‐Centered Multilingual Artificial Intelligence Home Monitoring Engages Refugee Pregnant Patients and Detects Elevated Blood Pressure Frances Conti‐Ramsden1; nina Sesto2; Jeanne Nizigiyimana3; Lora Nordstrom3; Dean Coonrod4; Alicia Willey3 1King's College London, London, United Kingdom; 2Megi Health Ltd, London, United Kingdom; 3Valleywise Health, Phoenix, AZ; 4Maricopa Medical Center, Phoenix, AZ Objective: This pilot assessed whether a community‐embedded, multilingual, artificial intelligence (AI) home‐monitoring platform can engage a pregnant refugee population and capture clinically relevant blood pressure (BP) and symptom data. Study Design: Prospective single‐arm pilot at a US refugee women's health clinic (Valleywise Health, Phoenix, Arizona). Cultural health navigators trained in high‐risk pregnancy invited pregnant women onto a smartphone platform pairing home BP self‐measurement, using a provided device, with a multilingual conversational AI companion. Patients were enrolled on a rolling basis between April and June 2026. Platform data were analyzed from first enrollment to 18 June 2026 (10‐week window). Platform engagement and BP readings were analyzed descriptively using Python 3.12.3. Results: Of 21 onboarded patients, 19 (90%) submitted at least one BP reading and 16 (76%) exchanged messages with the AI companion. Participants contributed 392 valid readings (mean 20.6, median 15, maximum 60 per patient) spanning gestational ages 5 to 40 weeks (all three trimesters) over a median of 27 days. Mean BP was 118 ± 2.1 / 76 ± 1.8 mmHg (per‐patient means, SEM). BP readings at or above 120/80 mmHg occurred in 17 of 19 monitoring patients (89%); 10 (53%) recorded a hypertensive‐range reading (at or above 140/90 mmHg) and 2 a severe‐range reading (at or above 160/110 mmHg). Overall, 47 readings (12%) were at or above 140/90 mmHg. Across 7 languages (Somali, Arabic, Swahili, Burmese, French, English, Pashto), patients sent 151 messages, reporting symptoms (headache, visual changes, swelling) and asking unprompted questions about BP thresholds, preeclampsia, and when to seek care; several users were routed to their cultural health navigator and the women's clinic. Conclusion: Community‐embedded multilingual AI‐supported home BP monitoring was feasible and well used in an underserved refugee pregnancy population. These findings support larger studies to enable early detection and management of hypertensive disorders of pregnancy in marginalized communities. 15:45 – 17:00 LB18 | Comparison of Perinatal Outcomes in Pregnant Women With Resistant Versus Non‐ Resistant Hypertension Mónica Paulina Fuentes Vélez1; Venance Basil Kway, Sr.2; Elian Yeritza Trujillo Cruz3; Andreu Comas García1 On behalf of Universidad Cuauhtémoc de San Luis Potosí 1Universidad Cuauhtémoc San Luis Potosí, San Luis Potosí, Mexico; 2Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico; 3Hospital Regional de Alta Especialidad “Dr. Ignacio Morones Prieto”, San Luis Potosí, Mexico Objective: To evaluate the association between resistant hypertension during pregnancy and adverse perinatal outcomes. Study Design: A retrospective cohort study was conducted on 254 pregnant women with hypertensive disorders treated at a tertiary‐level hospital between 2021 and 2024. Patients were classified into resistant hypertension (n = 54), defined as the need for three or more antihypertensive medications to achieve blood pressure control, and non‐resistant hypertension (n = 200). Maternal and neonatal variables were compared using χ2 tests, Student's t‐tests, or Mann‐Whitney U tests, as appropriate. Logistic regression was used to assess independent associations. Results: The study demonstrated significant results in the resistant hypertension group compared to the non‐resistant hypertension group. Women with resistant hypertension were older than nonresistant (30 vs 23 years, p < 0.001), had a higher prevalence of chronic hypertension, chronic kidney disease, and severe preeclampsia, and were diagnosed at an earlier gestational age (20 vs. 34 weeks, p < 0.001). Neonates born to mothers with resistant hypertension had a lower gestational age at delivery (33.5 vs. 38.1 weeks, p < 0.001) and lower birth weight. Resistant hypertension was associated with higher rates of prematurity (74.1% vs. 29.0%, p < 0.001), fetal growth restriction (36.0% vs. 14.1%, p < 0.001), NICU admission (70.0% vs. 13.2%, p < 0.001), respiratory distress syndrome (29.8% vs. 1.0%, p < 0.001), neonatal sepsis (44.7% vs. 6.1%, p < 0.001), and perinatal complications overall (64.8% vs. 16.0%, p < 0.001). Neonatal death was nearly ten times more frequent among pregnancies complicated by resistant hypertension (p = 0.002). Conclusion: These findings highlight resistant hypertension as an important marker of increased maternal and neonatal risk. Early identification of women at risk for resistant hypertension may improve maternal and neonatal outcomes through intensified surveillance and timely intervention. 15:45 – 17:00 LB19 | A Multicentre Cohort Study to Evaluate Specialist Antenatal Care in Pregnancies After Perinatal Death Alexander E. P. Heazell1; Emma Tomlinson1; Emilie Bailey2; Rebecca Barron2; Saima Arif1; Luke Munford1 1The University of Manchester, Manchester, United Kingdom; 2Saint Mary's Hospital, Manchester, United Kingdom Objective: The Tommy's National Rainbow Clinic Study aimed to evaluate the care provided using a novel, specialist approach in pregnancy after a perinatal death, to explore the impact on pregnancy outcome for women and their babies and identify areas for improvement. Study Design: This was a prospective cohort study of women attending Rainbow Clinics in the UK from 2020–2025. Participants were invited to complete psychometric assessments including GAD‐2, CWS and EPDS at recruitment (23 weeks). Participants’ experiences of attending Rainbow Clinic were recorded on a standardised participantexperience tool. Details of participants’ demographic characteristics, past obstetric history, number of scans and contacts and pregnancy outcomes were collected. Results: Data were obtained from 1,699 participants from 26 sites. Overall, participants had a mean of 9.5 ultrasound scans, 0.6 antenatal admissions, 10 midwife visits and 8.5 consultations with a doctor, with a mean of 20 antenatal contacts in total; there was significant variation across sites. Increased use of ultrasound scans and a greater number of visits was associated with reduced odds of recurrent stillbirth. Stillbirth occurred in 0.7% of participants (expected rate 2–2.5%). Preterm birth <37 weeks’ gestation occurred in 16.9% (expected rate 20%), <34 weeks’ gestation in 5.2% and 1.4% before 28 weeks’ gestation. A high proportion of births were by Caesarean section (56.0%), 16.1% of babies were admitted to the neonatal unit. There was variation in stillbirth, preterm birth <37 and <34 weeks’ gestation and neonatal unit admission between sites. There were improvements in GAD‐2, CWS and EPDS from baseline to the final questionnaire. Conclusion: This is the largest prospective study of women in pregnancy after loss. Variation in the frequency of consultations, frequency of ultrasound scans persists after the introduction of a specialist pregnancy after loss service. However, the rates of adverse outcome for women attending a specialist antenatal services were lower than previously reported and showed less variation between women of different ethnicities. 15:45 – 17:00 LB20 | Relaparotomy After Cesarean Delivery: Risk Factors and Outcomes – A Systematic Review and Meta‐Analysis Rula Iskander1; Manal Massalha2 1Emek Medical Center, Afula, Israel; 2McMaster University, Hamilton, Canada Objective: To determine the pooled incidence of relaparotomy following cesarean delivery and to identify maternal and surgical risk factors associated with this serious postoperative complication Study Design: We conducted a systematic review and meta‐analysis by searching MEDLINE, EMBASE, Web of Science, Scopus, the Cochrane Library, and ClinicalTrials.gov from inception till November 2025. Observational studies evaluating risk factors for relaparotomy following CD that included a control group of CD without relaparotomy were eligible for inclusion. Risk of bias was assessed using the ROBINS‐I tool, and certainty of evidence was evaluated using GRADE criteria. Pooled effect estimates were calculated using a random‐effects model, with Relative Risks (RR) calculated for categorical variables and weighted mean differences (WMD) for continuous variables Results: Fourteen studies met inclusion criteria, encompassing 164,007 patients, with 831 cases of relaparotomy. The pooled incidence of relaparotomy was 0.33%. Hemorrhage‐related etiologies accounted for 73.9% of indications, with intraperitoneal bleeding (30.4%) and postpartum hemorrhage (27.7%) being the most common causes. Significant maternal and surgical risk factors for relaparotomy included hypertensive disorders (RR 1.68), multiple gestation (RR 1.92), emergency CD (RR 1.23), prior CD (RR 1.64), placental indications for CD (RR 4.85), prolonged operative duration (WMD 9.35 minutes), and general anesthesia (RR 2.37). In the high‐income country subgroup, the clustering of older maternal age, hypertensive disorders, multiple gestation, lower gestational age, lower birth weight, and placental indications for CD suggested an association between relaparotomy and placental insufficiency Conclusion: Relaparotomy is rare but carries significant morbidity, primarily due to hemorrhage. Recognizing placental insufficiency‐related risk factors may help guide perioperative management to further reduce future severe complications. 15:45 – 17:00 LB21 | Comparing Vulnerable Newborn Classification Frameworks for Perinatal Risk Detection in a Sub‐Saharan African Cohort (PRECISE) Hawanatu Jah1; Helen Nabwera2; Yahaya Idris3; Angela Koech2; Grace Mwashigadi2; Sonia Maculuve4; Joseph Akuze5; Marie‐Laure Volvert6; Esperanca Sevene4; Marleen Temmerman2; Aris Papageorghiou7; Wessel Ganzevoort8; Umberto D'Alessandro3; Hannah Blencowe5; Peter von Dadelszen6 On behalf of 1 Medical Research Council unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia ‐ 2 Department of Obstetrics & Gynaecology, Amsterdam University Medical Center location University of Amsterdam, Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands ‐ 3 Centre of Excellence in Women and Child Health, Aga Khan University, Nairobi, Kenya ‐ 4 Liverpool School of Tropical Medicine, Liverpool, UK ‐ 5 Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique ‐ 6 Department of Women and Children's Health, School of Life Course and Population Sciences, Kings College London, London, UK ‐ 7 Department of Obstetrics and Gynaecology, University of British Columbia, Canada ‐ 8 Centre for Maternal Reproductive Adolescent, and Child Health (MARCH), London School of Hygiene & Tropical Medicine, London, UK ‐ 9 Department of Physiological Science, Clinical Pharmacology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique ‐ 10 International Centre for Reproductive Health, Ghent, Belgium ‐ 11 Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom 1Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; 2Aga Khan University, Nairobi, Kenya; 3Medical Research Council Unit The Gambia at LSHTM, Fajara, Gambia, The; 4Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique; 5London School of Hygiene and Tropical Medicine, London, United Kingdom; 6King's College London, London, United Kingdom; 7University of Oxford, Oxford, United Kingdom; 8Amsterdam UMC, Amsterdam Objective: The 2023 small vulnerable newborn (SVN) framework was proposed to replace low birthweight (LBW) alone for identifying at‐risk infants, but studies have applied heterogeneous definitions, and none has evaluated classification performance in sub‐Saharan Africa, where gestational age data are frequently incomplete. We compared three framework variations for identifying infants at risk of adverse perinatal outcomes. Study Design: We classified 5,812 births in the prospective PRECISE cohort (The Gambia, Kenya, Mozambique; 2019–2022) using three frameworks: clinical SVN (preterm and/or small‐for‐gestational‐age from available data), LBW (<2,500 g), and high‐burden vulnerable newborn (preterm‐SGA, preterm‐AGA, term‐SGA). Classification performance for stillbirth and critical newborn (death or admission within three days) was assessed using sensitivity, specificity, predictive values, likelihood ratios, and AUC on a common complete‐cases dataset. LBW was evaluated within at‐risk infants. Results: Clinical SVN achieved the highest sensitivity (stillbirth 84.6% [95% CI, 78.1–89.8]; critical newborn 70.3% [61.9–77.8]) and classified 88% of all stillbirths. LBW achieved the highest specificity (88.1–89.2%) but missed over half of affected infants. Among at‐risk infants, concurrent LBW conferred a 5‐ to 7.5‐fold additional risk. A combined SVN‐LBW framework added no independent value. Conclusion: Clinical SVN, functioning as a broad screening tool classifiable from partial data, is the most sensitive approach to identifying at‐risk newborns in data‐incomplete settings, while LBW adds prognostic value as a confirmatory severity marker within the at‐risk group. These findings support context‐dependent SVN adoption with investment in gestational age assessment in sub‐Saharan Africa. 15:45 – 17:00 LB22 | PhysioCare. Maternal Mental Health Six Weeks Postpartum: A Comparison of Alongside Midwifery and Obstetric‐Led Units Marion Monperrus1; Ronan Garlantezec2; Rémi Béranger1; Maela Le Lous3; Pauline Blanc‐Petitjean4; Yves Gallien1 1Centre Hospitalier Universitaire de Rennes, Rennes, France; 2University Hospital, Rennes, France; 3Department of Gynecology and Obstetrics, Centre Hospitalier Universitaire de Rennes (CHU Rennes), Rennes, France; 4Inserm (the French National Institute of Health and Medical Research), Paris, France Objective: In France, innovative alternative midwifery units (AMU) within hospital settings offer personalized care to low‐risk pregnant women, with a dedicated midwife during pregnancy and childbirth (non‐medicalized birthing room). We aimed to assess the influence of care provided in AMUs, compared with obstetric‐led units (OUs), on postpartum depression and other maternal mental health outcomes, including childbirth‐related post‐traumatic stress disorder, childbirth experience, and mother‐infant bonding within the first six weeks postpartum. Evidence regarding the psychological impact of birth setting remains limited. Study Design: PhysioCare is a prospective multicenter cohort study (exposed/unexposed, 1:2 ratio; matched by center and parity) including 597 low‐risk pregnant women (195 in AMUs and 402 in OUs) recruited between 34 and 39 weeks of gestation from September 2022 to April 2023 in three French maternity units, each including both an AMU and an OU. Data were obtained from medical records and self‐administered questionnaires at inclusion, two days (D2), and six weeks (W6) postpartum. Multivariable regression (logistic, linear and negative binomial) intention‐to‐treat analyses were performed using inverse probability of treatment weighting based on propensity scores, adjusting for maternal age, parity, BMI, education level, HADS and Prenatal Attachment Inventory scores, and center. Results: Among the 597 included women, questionnaire completion exceeded 90% at D2 and reached 83% at W6. AMU care was associated with lower EPDS rate ≥11 at W6 (ORa = 0.43; 95% CI, 0.21, 0.84) and with higher emotional scores on one subscale of the childbirth experience questionnaire at D2 (βa = −0.13; −0.22, −0.04) and W6 (βa = −0.16; −0.26, −0.05). OUs were associated with higher relationship‐with‐staff scores at D2, but this difference was no longer observed at W6. No significant differences were observed for other outcomes. Conclusion: AMU care was associated with improved maternal mental health in the early postpartum period, suggesting potential psychological benefits of midwifery‐led models for low‐risk women. 15:45 – 17:00 LB23 | Fetal Anomaly Diagnosis, Pregnancy‐Specific Anxiety, and Self‐Stigma Among Ghanaian Women Perez Sepenu1; Alim Swarray‐Deen2; Emma Lawrence3; Naa Akushia Sepenu1; Sally O. Manu1; Victor Etwire2; William Appeadu‐Mensah2; Hope Glover‐Addy2; Sherif K. Ahmed1; Beatrice Williams1; Masha Boi Bashiru1; Joseph Osafo‐Adu4; Theodore K. Boafor2; Jerry Coleman1; Samuel Antwi Oppong2; Kobinah Nkyekyer2 1Korle Bu Teaching Hospital, Accra, Ghana; 2University of Ghana Medical School, Accra, Ghana; 3University of Michigan, Ann Arbor, MI; 4University of Ghana, Accra, Ghana Objective: To determine whether fetal anomaly diagnosis is associated with psychological morbidity, stigma, coping, and resilience among pregnant women in a low‐resource setting. Study Design: We performed a prospective observational analysis of pregnant women undergoing fetal anomaly assessment at a tertiary referral center in Ghana from January to June 2026. Women with a fetal anomaly diagnosis were compared with women with normal fetal anatomy. Validated instruments assessed depression, generalized anxiety, stress, pregnancy‐specific anxiety, psychological distress, parental self‐stigma, resilient coping, and resilience. Group differences were tested nonparametrically. Robust multivariable linear models adjusted for maternal age, gestational age, education, marital status, and perceived social support. Results: Among 184 women, 57 had a fetal anomaly and 127 had normal fetal anatomy; 182 had complete psychological scales. Pregnancy‐specific anxiety was substantially higher with fetal anomaly, median Pregnancy‐Related Anxiety Questionnaire score 30.0 (IQR 23.5–37.3) versus 20.0 (IQR 12.3–27.0), p < 0.001. The largest difference involved worry about the affected child, 18.5 (IQR 13.3–22.0) versus 10.0 (IQR 5.0–13.8), p < 0.001. Parental self‐stigma was also higher, median 23.0 (IQR 12.0–26.0) versus 13.0 (IQR 12.0–20.0), p < 0.001. After adjustment, fetal anomaly remained associated with 7.37 more pregnancy‐anxiety points (95% CI, 3.28–11.46) and 5.70 more self‐stigma points (95% CI, 2.06–9.34). Depression, generalized anxiety, stress, distress, coping, and resilience scores did not differ significantly. Conclusion: Fetal anomaly diagnosis produced a domain‐specific psychological burden dominated by concern for the child and internalized parental stigma, which generic depression and anxiety screens largely missed. Fetal medicine services in low‐resource settings should pair routine mental‐health screening with pregnancy‐specific anxiety and stigma assessment and targeted psychosocial support. 15:45 – 17:00 LB24 | Improving Sexual Reproductive Health for Migrant Women: Trends From Mobile Clinic Care and Curriculum Development Ruth Woldemichael1; Victoria Mui2 1Baylor College of Medicine; Penn Medicine, Houston, TX; 2University of Pennsylvania, Philadelphia, PA Objective: Migrant and refugee women experience disproportionately high rates of sexual violence, unintended pregnancy, and STIs while facing substantial barriers to healthcare. We aimed to develop a community‐informed, evidence‐based sexual and reproductive health (SRH) curriculum for multidisciplinary mobile clinic providers serving migrant women in Mexico City. Study Design: A multilingual, cross‐sectional needs assessment was conducted across five Médecins Sans Frontières (MSF) mobile clinic sites in Mexico City. Surveys and consultations identified priority SRH needs and barriers to care among migrant women and gender‐diverse individuals. Findings and guidelines from WHO, MSF, ACOG, and SMFM informed development of a standardized curriculum for providers. Results: A multilingual needs assessment identified family planning, STI prevention, antenatal care, and trauma‐informed sexual violence response as priority SRH needs. Between January and October 2025, MSF mobile clinics provided 20,273 multidisciplinary consultations across five sites in Mexico City. Common barriers included fear of deportation, discrimination, repeated displacement, and limited health literacy. From May 2025 through April 2026, the clinic completed 240 family planning visits, including 60% contraceptive initiation, 18% follow‐up, 15% counseling‐only, and 10% discontinuation visits. The etonogestrel implant was the most commonly selected contraceptive method (n = 20). In contrast, only 44 prenatal visits were completed, reflecting fragmented antenatal care. These findings informed development of a five‐module curriculum addressing antenatal care, STI prevention, contraception, trauma‐informed sexual violence response, and perinatal mental health. Conclusion: Despite high utilization of family planning services, inconsistent prenatal care highlighted persistent barriers to maternal healthcare among migrant women. A community‐informed, evidence‐based SRH curriculum offers a feasible implementation strategy to standardize multidisciplinary care and strengthen maternal and reproductive health services within humanitarian mobile clinics.